Common questions about Exparel (FAQ)
Q: What is Exparel used for besides surgery?
Official documents state that Exparel is indicated only for use in patients 6 years of age and older for single-dose infiltration to produce postsurgical local analgesia (pain relief in a specific area) following a surgical procedure. The regulatory approvals cover its use either via local infiltration or as a regional nerve block. Use for other types of analgesia, such as chronic pain, is not established in the product labeling.
Q: Is Exparel safe for elderly patients?
Regulatory information advises that bupivacaine, the active ingredient, is advised to be used with caution in older adults (65 years and older). This population may require close monitoring by a healthcare professional due to a potentially greater risk of toxic reactions.
Q: Can Exparel be used for chronic pain, or just after surgery?
Exparel is indicated exclusively for managing acute pain that occurs after a surgical procedure. Its safety and effectiveness for treating other pain conditions, including various forms of chronic pain, have not been established in the official prescribing information.
Q: Why would a doctor choose Exparel over another type of nerve block?
The primary difference is the DepoFoam liposomal delivery system. This special formulation allows the active ingredient, bupivacaine, to be released gradually into the tissue over a prolonged period. This unique mechanism is designed to prolong the duration of the analgesic effect compared to standard, short-acting local anesthetics.
Q: Is there a risk of permanent nerve damage from Exparel?
Regulatory information indicates the medicine may cause a temporary loss of feeling and/or muscle movement, which may last up to five days. Like all bupivacaine products, there is a risk of Systemic Local Anesthetic Toxicity (LAST), a serious condition that can affect the central nervous system and heart. Regulatory documents do not specifically list permanent nerve damage as a common or serious risk.
Q: Is Exparel approved for use in women who are pregnant or breastfeeding?
Official labeling states that Exparel is not recommended for women who are pregnant. Use during pregnancy may seriously harm the unborn baby if used for obstetrical paracervical block. Bupivacaine also passes into breast milk, and the healthcare provider will determine whether continuing breastfeeding or receiving the treatment is appropriate.
Q: Is it possible to receive Exparel if I have kidney or liver problems?
Official information advises caution for patients with hepatic (liver) or renal (kidney) disease because the liver metabolizes the drug and the kidneys excrete it. These patients are at a greater risk of developing toxic plasma concentrations and require monitoring.
Q: Why does Exparel need to be injected right into the surgical site?
Exparel is an anesthetic designed to work locally, meaning it is only effective in the area where it is injected. Regulatory information specifies administration should be only via local infiltration or specific nerve blocks. Injecting it into blood vessels, joints, or the spine is restricted because it greatly increases the risk of serious adverse reactions.
Q: Is it common to feel numbness where Exparel was injected?
As a local anesthetic, a loss of sensation or numbness is the intended effect in the surgical area. The official label notes that this temporary loss of feeling or muscle movement may last for up to five days after the injection is administered.
Q: Does Exparel wear off suddenly, or does the effect fade slowly?
The formulation is designed for a gradual, sustained release of the active ingredient through a process called bioerosion. This mechanism typically results in the analgesic effect fading slowly over time, rather than ceasing abruptly.
Q: Are there any long-term side effects reported with Exparel?
Based on the clinical data and current post-market surveillance, regulatory review documents have not identified any known long-term safety issues associated with Exparel.
Q: What types of surgeries is Exparel most often used for?
Exparel is used for postsurgical pain control across many specialties. The clinical studies that supported its approval included specific procedures such as total shoulder arthroplasty, rotator cuff repair, bunionectomy, and hemorrhoidectomy.
Q: Does Exparel interact with common over-the-counter pain relievers like ibuprofen?
No direct drug-drug interaction between Exparel and common nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen is reported in the official labeling. Official information emphasizes disclosing all medications, including OTC pain relievers, to the healthcare provider.
Q: Are there specific instructions for activity right after receiving Exparel?
Because Exparel can cause a temporary loss of feeling and/or muscle movement for up to five days, official guidance indicates caution may be needed after receiving the injection. The ability to perform activities that require feeling or full muscle control in the treated area may be impaired.
Q: Do studies support the use of Exparel for joint replacement recovery?
Yes, clinical trials supported the use of Exparel for regional analgesia in adults undergoing procedures such as total shoulder arthroplasty, which is a form of joint replacement surgery.
Q: Does having Exparel affect my ability to drive or operate machinery?
Official safety information indicates that Exparel may cause dizziness, drowsiness, or a temporary loss of feeling and movement for up to 5 days. Official safety information advises against driving or operating machinery until the effects have fully resolved and the patient understands how the medicine affects them.
Q: What is the experience like when the medication starts to work?
The intended effect is a loss of feeling or temporary loss of muscle movement in the area where the medicine was injected. Official information notes that early signs of systemic toxicity, such as tingling or numbness around the mouth or a metallic taste, should be reported to the healthcare team.
Q: What should I tell my doctor before getting Exparel?
Official labeling emphasizes disclosing all existing health conditions, particularly heart, liver, or kidney problems. Additionally, this includes all prescription, over-the-counter, vitamin, mineral, and herbal products currently being used.
Q: Does Exparel contain steroids?
No, the official product description specifies that the medicine's components are the active ingredient, bupivacaine, and the DepoFoam liposomal delivery system. Steroids are not listed as an ingredient in this formulation.
Q: Does Exparel work on inflammation as well as pain?
The regulatory documents describe the drug’s mechanism as acting on the nerve cell membrane to block the transmission of pain signals. The official product information does not state that it possesses anti-inflammatory properties.
Q: What is the chance of having an allergic reaction to Exparel?
Allergic reactions are a potential, though rare, risk associated with Exparel. Clinical trial data indicates that allergic-type reactions occurred with a frequency of less than 0.1% of patients.
Q: Are there certain medications that must be stopped before getting Exparel?
Regulatory documents restrict the use of other non-bupivacaine local anesthetics around the time of Exparel administration. If a different local anesthetic is administered first, regulatory guidance requires its administration to be spaced out by at least 20 minutes before Exparel is injected.
Q: If the Exparel injection site is sore, is that normal?
Clinical trials reported that common adverse reactions included procedural pain and post-procedural swelling at the injection site. These local effects can contribute to a feeling of soreness.
Q: Does the efficacy of Exparel change based on the type of incision or wound?
Official dosing guidelines state that the recommended dose of Exparel is based on the size of the surgical site and the volume required to cover the area. This indicates that the extent and type of the wound are factors in how the medicine is administered to ensure efficacy.
